Related references
Note: Only part of the references are listed.Treatment of alopecia areata in pre-adolescent children with oral tofacitinib: A retrospective study
Rebekka Jerjen et al.
PEDIATRIC DERMATOLOGY (2021)
Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta-analysis
L. Guo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study
Elise A. Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Ruxolitinib for the treatment of severe alopecia areata
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
George E. Fragoulis et al.
RHEUMATOLOGY (2019)
JAK inhibitors for alopecia areata: a systematic review and meta-analysis
K. Phan et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
JAK inhibitors and alopecia areata
Amos Gilhar et al.
LANCET (2019)
Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
Neslihan Akdogan et al.
DERMATOLOGIC THERAPY (2019)
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Farzan Solimani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pathomechanisms of immune-mediated alopecia
Alessandra Anzai et al.
INTERNATIONAL IMMUNOLOGY (2019)
An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
Rachel Berbert Ferreira et al.
CLINICAL CASE REPORTS (2019)
A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient
Nupur U. Patel et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
A. Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Alopecia areata is a medical disease
Dorota Z. Korta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Carcinogenicity assessment of baricitinib in Tg.rasH2 mice and SpragueDawley (Crl:CD) rats
Mark Carfagna et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
JAK Inhibitors for Treatment of Alopecia Areata
Eddy H. C. Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Role of janus kinase inhibitors in the treatment of alopecia areata
Korn Triyangkulsri et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
Yuval Ramot et al.
SKIN APPENDAGE DISORDERS (2018)
Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
Ralph M. Trueb et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
Amy Vandiver et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
Maya Deeb et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)
Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
Hyun-Sun Park et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
Leslie Castelo-Soccio
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Tofacitinib for the treatment of alopecia areata and variants in adolescents
Brittany G. Craiglow et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
Cheryl B. Bayart et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
JAK inhibitors in dermatology: The promise of a new drug class
William Damsky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
SUCCESSFUL HAIR REGROWTH IN A KOREAN PATIENT WITH ALOPECIA UNIVERSALIS FOLLOWING TOFACITINIB TREATMENT
Bo Young et al.
SINGAPORE MEDICAL JOURNAL (2017)
Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
Morton Scheinberg et al.
RHEUMATOLOGY AND THERAPY (2017)
Excellent response to tofacitinib treatment in a patient with alopecia universalis
Funda Erduran et al.
ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA (2017)
The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
Yael Renert-Yuval et al.
ADVANCES IN THERAPY (2017)
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
Ali Jabbari et al.
EXPERIMENTAL DERMATOLOGY (2016)
Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
Lynn Petukhova et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
John E. Harris et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine
Sergio Vano-Galvan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Efficacy of tofacitinib in treatment of alopecia universalis in two patients
A. K. Gupta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Milene Kennedy Crispin et al.
JCI INSIGHT (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
Florian Anzengruber et al.
CASE REPORTS IN DERMATOLOGY (2016)
Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
Sineida Berbert Ferreira et al.
CASE REPORTS IN DERMATOLOGY (2016)
The role of lymphocytes in the development and treatment of alopecia areata
Hongwei Guo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
Eleanor Higgins et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
Regina C. Betz et al.
NATURE COMMUNICATIONS (2015)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Ali Jabbari et al.
EBIOMEDICINE (2015)
Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia
Lisa Pieri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Epidemiology and burden of alopecia areata: a systematic review
Alexandra C. Villasante Fricke et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2015)
Efficacy and safety of methotrexate in alopecia areata
Mariana Hammerschmidt et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2014)
Therapeutic Targeting of the JAK/STAT Pathway
Saara Aittomaki et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
Brittany G. Craiglow et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
Jack G. Shi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Interventions for alopecia areata
F. M. Delamere et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Stress in patients with alopecia areata and vitiligo
Liana Manolache et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Transfer of CD8+ cells induces localized hair loss whereas CD4+/CD25- cells promote systemic alopecia areata and CD4+/CD25+ cells blockade disease onset in the C3H/HeJ mouse model
KJ McElwee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
The role of psychological factors in alopecia areata and the impact of the disease on the quality of life
AT Gülec et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
The hair follicle and immune privilege
R Paus et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2003)
Share Paper
